SUPPLEMENTARY MATERIALS Impact Of Compliance With
SUPPLEMENTARY MATERIALSImpact of compliance with GOLD treatment recommendations on COPD health care resourceutilization, cost, and exacerbations among COPD patients on maintenance therapySwetha R Palli, MS; Siting Zhou, PhD; Asif Shaikh, MD; and Vincent J Willey, PharmDSupplementary Table 1 – Validated claims-based algorithm predictors for COPD cases to identifypatients with COPDSupplementary Table 2 – COPD maintenance medications and COPD/pneumonia diagnosis codesSupplementary Table 3 – 2017 Global Initiative for Chronic Obstructive Lung Disease (GOLD)Treatment recommendations by GOLD A/B/C/D risk group for determining compliance to GOLDSupplementary Table 4 – Covariate list include for all multivariate models at the start of backwardselection processSupplementary Table 5a – Unadjusted all-cause and COPD-related healthcare encounters overfollow-up for GOLD A/B and C/D risk groupsSupplementary Table 5b – Unadjusted all-cause and COPD-related costs over follow-up for GOLDA/B and C/D risk groupsPage 1 of 21
Supplementary Table 1 – Validated claims-based algorithm predictors for COPD cases to identify patientswith COPD*Predictors of COPD casesPredictorsPredictors of non-COPD 95Obstructive sleep apnea-0.5298 3 claims diagnoses of COPD with 30 days0.6484Pulmonary fibrosis-0.4165apart from each otherPresence of Pulmonary rehabilitation0.4960Female-0.2943Number of COPD inpatient hospitalizations0.2021Peptic ulcer/gastroesophageal reflux disease-0.2781Presence of smoking codes in claims0.1838Allergic rhinitis-0.2554Number of COPD ED visits0.0915Myocardial infarction-0.1748Number of COPD office visits0.0814Hypertension-0.1473Number of LAMA claims0.0578Antibiotic use-0.1414Number of visits to pulmonologist0.0394Ischemic heart disease-0.0583Presence of Respiratory failure0.0319Chronic sinusitis-0.0526Number of SABA claims0.0295Pneumonia-0.0508Number of ICS-LAMA claims0.0268Depression-0.0352Number of LAMA-LABA claims0.0239Count of supplemental oxygen use0.0089*When COPD-confirmatory spirometry data is unavailableModel characteristics: Sensitivity: 0.672; Specificity: 0.670; Area under curve: 0.73; Predicted probability threshold: 0.75; Crossvalidated Positive Predictive Value (95% CI): 0.860 (0.840 - 0.880)Reference: Palli S, Zhou S, Shaikh A, Willey V. Developing a claims’-based algorithm to identify US patients with COPD. EurRespir J. Sep 2019, 54 (suppl 63) PA4431COPD chronic obstructive pulmonary disease; CI confidence interval; ED emergency department; ICS inhaled corticosteroid;LABA long-acting beta-2 agonist; LAMA long-acting muscarinic antagonists; SABA short-acting beta2-agonistPage 2 of 21
Supplementary Table 2 – COPD maintenance medications and COPD/pneumonia diagnosis codesMedication classInhaled corticosteroids (ICS)All eFlunisolideFluticasoneMometasoneTriamcinoloneLong acting beta-2 agonist(LABA)Inhaled ormoterolOlodaterol HCIOral LABAsVospireVolmaxProventil CRLong-acting muscarinicantagonists um e/indacaterolTiotropium BromideOlodaterol gnosisGPI code starts 4000334440003644400040HCPCSJ7622J7626, J7627, J7633, J7634J7641J7683, 052J7606, J7640, D-9-CMCOPD491.xx, 492.xx, 496.xxPneumonia011.62, 011.63, 011.64, 011.65,011.66, 052.1, 055.1, 073.0,115.05, 115.15, 115.95, 130.4,480.0, 480.1, 480.2, 480.3, 480.8,480.9, 481, 482.0, 482.1, 482.2,482.30, 482.31, 482.32, 48H2.39,Page 3 of 21ICD-10-CMJ41.xx, J42.xx, J43.xx,J44.xxA0103, A0222, A3701,A3711, A3781, A3791,A481, A5484, B012, B052,B0681, B250, B440, J09X1,J1000, J1001, J1008, J1100,J1108, J120, J121, J122,
482.40, 482.41, 482.42, 482.49,J123, J1281, J1289, J129,482.81, 482.82, 482.83, 482.84,J13, J14, J150, J151, J1520,482.89, 482.9, 483.0, 483.1,J15211, J15212, J1529, J153,483.8, 484.1, 484.3, 484.6, 484.7, J154, J155, J156, J157, J158,484.8, 485, 486, 487.0, 488.01,J159, J160, J168, J17, J180,488.11, 488.81, 495.7, 495.8,J18, J182, J188, J189, J200,495.9, 506.0, 507.0, 507.1, 507.8, J678, J679, J680, J690, J691,516.30, 516.32, 516.33, 516.35,J698, J84111, J84113,516.36, 516.37, 517.1, 997.31,J84114, J84116, J84117,997.32J842, J851, J954, J95851COPD chronic obstructive pulmonary disease; GPI generic product identifier; HCPCS Healthcare Common Procedure CodingSystem; ICD-x-CM International Classification of Disease Clinical Modification; ICS inhaled corticosteroid; LABA longacting beta-2 agonist LAMA long-acting muscarinic antagonistsPage 4 of 21
Supplementary Table 3— 2017 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Treatmentrecommendations by GOLD A/B/C/D risk group for determining compliance to GOLDPatientRiskGroupTreatments in the12 months preindex periodABCDIndex treatmentsSABA, LABA, SAMA, or LAMAIf no prior COPDmedicationsLABA or LAMAIf with prior use ofLABA or LAMALAMA LABA combination therapyIf no prior COPDmedicationsLAMAIf with prior use ofLAMALAMA LABA combination therapyORICS LABA combination therapyIf no prior COPDmedicationsLABA LAMA or LAMAIf with prior use ofLAMALAMA LABA combination therapyORICS LABA combination therapyIf with prior use ofLAMA LABA orICS LABALAMA LABA ICS combination therapyCOPD chronic obstructive pulmonary disease; GOLD Global Initiative for Chronic Obstructive Lung Disease; ICS inhaledcorticosteroid; LABA long-acting beta2-agonist; LAMA long-acting muscarinic antagonists; SABA short-acting beta2-agonist;SAMA short-acting muscarinic antagonistsPage 5 of 21
Supplementary Table 4 – Covariate list include for all multivariate models at the start of backward selection processOutcomeTime to firstCOPDexacerbationTime to firstsevere COPDexacerbationNumber ofCOPDinpatientadmissionsCovariates retained after backwards selectionGOLD A/BFemale, Region of residence, Medicare advantage, index treatingprovider specialty, index year (2014-17), baseline anxiety, baselinechronic sinusitis, baseline diabetes mellitus, baseline ischemicheart disease, baseline Osteoporosis, baseline Pneumonia, age,baseline Elixhauser comorbidity index score, baseline COPD totalcosts, baseline COPD total medical costs, baseline exacerbationcountsFemale, Region of residence, Medicare advantage, index treatingprovider specialty, index year (2014-17), baseline anxiety, baselinedyspnea, baseline congestive heart failure, baseline peripheralvascular disease, baseline obstructive sleep apnea, baselinepneumonia, age, Baseline Elixhauser comorbidity index score,baseline COPD total costs, baseline COPD total medical costs,baseline exacerbation counts, baseline exacerbation episode costsRegion of residence, Medicare advantage, index treating providerspecialty, baseline anxiety, baseline dyspnea, baseline congestiveheart failure, baseline angina pectoris, baseline ischemic heartdisease, baseline peripheral vascular disease, baseline renaldisease, baseline pneumonia, age, baseline Elixhauser comorbidityindex score, baseline exacerbation counts, baseline all-cause EDuse, baseline all-cause other outpatient visit use, baseline COPDinpatient use, baseline COPD office visit use, baseline all-causeinpatient counts, baseline all-cause outpatient counts, baselineCOPD inpatient counts, baseline COPD ED visit counts, baselineCOPD office visit counts, baseline COPD outpatient counts,baseline all-cause total costs, baseline all-cause medical costs,baseline all-cause inpatient costs, baseline all-cause ED costs,baseline all-cause office visit costs, baseline all-cause otheroutpatient visit costs, baseline COPD ED costsGOLD C/DMedicare advantage, baseline chronic sinusitis, baseline congestiveheart failure, baseline osteoporosis, baseline renal disease, age,baseline COPD total costs, baseline COPD total medical costs,baseline exacerbation counts, baseline severe exacerbation counts,baseline moderate exacerbation episode costsMedicare advantage, index treating provider specialty, baselineanxiety, baseline diabetes mellitus, baseline dyspnea, baselinecongestive heart failure, baseline peripheral vascular disease, baselineosteoporosis, baseline obstructive sleep apnea, baseline pneumonia,age, baseline COPD total costs, baseline COPD total medical costs,baseline exacerbation counts, baseline severe exacerbation counts,baseline exacerbation episode costs, baseline moderate exacerbationepisode costsMedicare advantage, index treating provider specialty, baselineanxiety, baseline dyspnea, baseline congestive heart failure, baselineangina pectoris, baseline ischemic heart disease, baseline pneumonia,age, baseline Elixhauser comorbidity index score, baselineexacerbation counts, baseline all-cause ED flag, baseline COPDinpatient flag, baseline COPD ED flag, baseline all-cause ED counts,baseline COPD inpatient counts, baseline COPD outpatient counts,baseline all-cause total costs, baseline COPD inpatient costsPage 6 of 21
Number ofCOPD EDvisitsNumber ofCOPD officevisitsNumber ofCOPD otheroutpatientvisitsFemale, Medicare advantage, index treating provider specialty,index year (2014-17), baseline anxiety, baseline ischemic heartdisease, age, baseline Elixhauser comorbidity index score, baselineexacerbation counts, baseline all-cause ED use, baseline all-causeoffice visit use, baseline COPD inpatient use, baseline COPD EDuse, baseline all-cause ED counts, baseline COPD ED visit counts,baseline COPD office visit counts, baseline COPD outpatientcounts, baseline all-cause total costs, baseline all-cause otheroutpatient visit costsFemale, health plan type, index treating provider specialty, indexyear (2014-17), baseline anxiety, baseline diabetes mellitus,baseline dyspnea, baseline congestive heart failure, baselinemyocardial infarction, baseline acute ischemic heart disease,baseline peripheral vascular disease, baseline pneumonia, age,baseline Elixhauser comorbidity index score, baseline COPD totalcosts, baseline COPD total medical costs, baseline exacerbationcounts, baseline exacerbation episode costs, baseline all-causeoffice visit use, baseline all-cause other outpatient visit use,baseline COPD inpatient use, baseline COPD office visit use,baseline COPD other outpatient use, baseline all-cause inpatientcounts, baseline all-cause ED counts, baseline all-cause office visitcounts, baseline all-cause outpatient counts, baseline COPD officevisit counts, baseline COPD outpatient counts, baseline all-causetotal costs, baseline all-cause medical costs, baseline all-causeinpatient costs, baseline all-cause ED costs, baseline all-causeoffice visit costs, baseline all-cause other outpatient visit costsFemale, health plan type, Medicare advantage, index treatingprovider specialty, index year (2014-17), baseline anxiety, baselinedyspnea, baseline congestive heart failure, baseline angina pectoris,baseline renal disease, baseline obstructive sleep apnea, baselinepneumonia, age, baseline Elixhauser comorbidity index score,baseline COPD total medical costs, baseline exacerbation episodecosts, baseline all-cause office visit use, baseline COPD inpatientuse, baseline COPD ED use, baseline COPD office visit use,baseline COPD other outpatient use, baseline all-cause inpatientcounts, baseline all-cause office visit counts, baseline all-causeoutpatient counts, baseline COPD ED visit counts, baseline COPDoffice visit counts, baseline COPD outpatient counts, baseline allcause medical costs, baseline all-cause inpatient costs, baseline all-baseline anxiety, baseline dyspnea, baseline ischemic heart disease,baseline all-cause ED flag, baseline COPD inpatient flag, baselineCOPD ED flag, baseline all-cause ED counts, baseline COPDinpatient counts, baseline COPD ED visit counts, baseline COPDoutpatient counts, baseline all-cause total costsIndex treating provider specialty, baseline dyspnea, baselinehypertension, baseline COPD total medical costs, baselineexacerbation counts, baseline all-cause office visit flag, baseline allcause other outpatient visit flag, baseline COPD inpatient flag,baseline COPD office visit flag, baseline all-cause inpatient counts,baseline all-cause ED counts, baseline all-cause office visit counts,baseline all-cause outpatient counts, baseline COPD office visitcounts, baseline all-cause medical costs, baseline all-cause inpatientcosts, baseline all-cause ED costs, baseline all-cause office visit costs,baseline all-cause other outpatient visit costs, baseline COPD inpatientcosts, baseline COPD outpatient countsFemale, Medicare advantage, baseline dyspnea, baseline renal disease,age, baseline Elixhauser comorbidity index score, baseline COPD totalcosts, baseline COPD total medical costs, baseline exacerbationcounts, baseline exacerbation episode costs, baseline all-cause EDflag, baseline COPD inpatient flag, baseline COPD ED flag, baselineCOPD office visit flag, baseline COPD other outpatient flag, baselineCOPD outpatient counts, baseline all-cause other outpatient visit costs,baseline COPD office visit countsPage 7 of 21
cause ED costs, baseline all-cause office visit costs, baseline allcause other outpatient visit costs, baseline COPD inpatient costs,baseline COPD ED costs, baseline COPD office visit counts,baseline COPD outpatient countsTotal COPDcostsCOPDMedical costsFemale, region of residence, Medicare advantage, index treatingprovider specialty, index year (2014-17), baseline chronic sinusitis,baseline diabetes mellitus, baseline dyspnea, baseline congestiveheart failure, baseline myocardial infarction, baseline acuteischemic heart disease, baseline angina pectoris, baselineperipheral vascular disease, baseline renal disease, baselinepneumonia, age, baseline Elixhauser comorbidity index score,baseline COPD total costs, baseline COPD total medical costs,baseline exacerbation episode costs, baseline all-cause otheroutpatient visit use, baseline COPD inpatient use, baseline COPDoffice visit use, baseline all-cause inpatient counts, baseline allcause ED counts, baseline COPD ED visit counts, baseline COPDoffice visit counts, baseline COPD outpatient counts, baseline allcause total costs, baseline all-cause medical costs, baseline allcause inpatient costs, baseline all-cause ED costs, baseline allcause office visit costs, baseline all-cause other outpatient visitcosts, baseline COPD inpatient costs, baseline COPD ED costsFemale, region of residence, Medicare advantage, index treatingprovider specialty, baseline chronic sinusitis, baseline diabetesmellitus, baseline dyspnea, baseline congestive heart failure,baseline myocardial infarction, baseline acute ischemic heartdisease, baseline peripheral vascular disease, baseline renaldisease, baseline pneumonia, age, baseline Elixhauser comorbidityindex score, baseline COPD total costs, baseline COPD totalmedical costs, baseline all-cause ED use, baseline COPD inpatientuse, baseline COPD office visit use, baseline all-cause inpatientcounts, baseline all-cause ED counts, baseline COPD ED visitcounts, baseline COPD office visit counts, baseline COPDoutpatient counts, baseline all-cause total costs, baseline all-causemedical costs, baseline all-cause inpatient costs, baseline all-causeED costs, baseline all-cause office visit costs, baseline all-causeother outpatient visit costs, baseline COPD inpatient costs, baselineCOPD ED costsFemale, Medicare advantage, baseline chronic sinusitis, baselinedyspnea, baseline congestive heart failure, baseline myocardialinfarction, baseline angina pectoris, baseline ischemic heart disease,baseline renal disease, baseline ischemic stroke, baseline pneumonia,baseline Elixhauser comorbidity index score, baseline COPD totalcosts, baseline COPD total medical costs, pre-index all-cause inpatientflag, baseline all-cause ED flag, baseline all-cause office visit flag,baseline all-cause other outpatient visit flag, baseline COPD ED flag,baseline all-cause office visit counts, baseline COPD inpatient counts,baseline COPD outpatient counts, baseline all-cause medical costs,baseline all-cause inpatient costs, baseline all-cause ED costs, baselineall-cause office visit costs, baseline all-cause other outpatient visitcosts, baseline COPD inpatient costs, baseline COPD ED costsFemale, Medicare advantage, index year (2014-17), baseline chronicsinusitis, baseline dyspnea, baseline congestive heart failure, baselinemyocardial infarction, baseline pneumonia, baseline Elixhausercomorbidity index score, baseline COPD total medical costs, preindex all-cause inpatient flag, baseline all-cause ED flag, baseline allcause office visit flag, baseline COPD ED flag, baseline all-causeoffice visit counts, baseline COPD inpatient counts, baseline COPDoutpatient counts, baseline all-cause medical costs, baseline all-causeinpatient costs, baseline all-cause ED costs, baseline all-cause officevisit costs, baseline all-cause other outpatient visit costs, baselineCOPD inpatient costs, baseline COPD ED costsPage 8 of 21
InpatientcostsER costsOffice visitcostsFemale, region of residence, Medicare advantage, index treatingprovider specialty, baseline chronic sinusitis, baseline diabetesmellitus, baseline dyspnea, baseline congestive heart failure,baseline myocardial infarction, baseline acute ischemic heartdisease, baseline peripheral vascular disease, baseline renaldisease, baseline pneumonia, age, baseline Elixhauser comorbidityindex score, baseline COPD inpatient use, baseline COPD officevisit use, baseline all-cause inpatient counts, baseline all-cause EDcounts, baseline COPD ED visit counts, baseline COPD outpatientcounts, baseline all-cause total costs, baseline all-cause medicalcosts, baseline all-cause inpatient costs, baseline all-cause EDcosts, baseline all-cause office visit costs, baseline all-cause otheroutpatient visit costs, baseline COPD ED costsRegion of residence, Medicare advantage, index treating providerspecialty, index year (2014-17), baseline anxiety, baselinecongestive heart failure, baseline hypertension, baseline acuteischemic heart disease, baseline ischemic heart disease, baselineperipheral vascular disease, baseline COPD total costs, baselineCOPD total medical costs, baseline exacerbation counts, baselineall-cause inpatient use, baseline all-cause ED use, baseline allcause office visit use, baseline COPD ED use, baseline COPDoffice visit use, baseline all-cause ED counts, baseline COPDinpatient counts, baseline COPD office visit counts, baselineCOPD outpatient counts, baseline all-cause total costs, baseline allcause inpatient costs, baseline all-cause ED costs, baseline allcause office visit costs, baseline all-cause other outpatient visitcosts, baseline COPD outpatient countsFemale, region of residence, Medicare advantage, index treatingprovider specialty, index year (2014-17), baseline diabetesmellitus, baseline dyspnea, baseline hypertension, baselinepneumonia, age, baseline Elixhauser comorbidity index score,baseline COPD total costs, baseline COPD total medical costs,baseline exacerbation counts, baseline exacerbation episode costs,baseline all-cause office visit use, baseline all-cause otheroutpatient visit use, baseline COPD inpatient use, baseline allcause inpatient counts, baseline all-cause ED counts, baseline allcause office visit counts, baseline all-cause outpatient counts,baseline COPD office visit counts, baseline COPD outpatientcounts, baseline all-cause total costs, baseline all-cause medicalIndex year (2014-17), baseline chronic sinusitis, baseline dyspnea,baseline congestive heart failure, baseline pneumonia, baselineElixhauser comorbidity index score, baseline COPD total medicalcosts, pre-index all-cause inpatient flag, baseline all-cause ED flag,baseline all-cause office visit flag, baseline all-cause office visitcounts, baseline all-cause medical costs, baseline all-cause inpatientcosts, baseline all-cause ED costs, baseline all-cause other outpatientvisit costs, baseline COPD inpatient costsFemale, region of residence, Medicare advantage, baseline chronicsinusitis, baseline dyspnea, baseline congestive heart failure, baselinehypertension, baseline ischemic heart disease, baseline exacerbationepisode costs, baseline all-cause ED flag, baseline all-cause otheroutpatient visit flag, baseline COPD inpatient flag, baseline all-causeinpatient counts, baseline COPD ED visit counts, baseline all-causetotal costs, baseline all-cause ED costs, baseline COPD outpatientcountsMedicare advantage, index treating provider specialty, baselinediabetes mellitus, baseline dyspnea, baseline congestive heart failure,age, baseline COPD total medical costs, baseline exacerbation counts,baseline all-cause office visit flag, baseline all-cause other outpatientvisit flag, baseline COPD inpatient flag, baseline COPD otheroutpatient flag, baseline all-cause inpatient counts, baseline all-causeED counts, baseline COPD ED visit counts, baseline COPD officevisit counts, baseline COPD outpatient counts, baseline all-causemedical costs, baseline all-cause inpatient costs, baseline all-causeoffice visit costs, baseline all-cause other outpatient visit costs,baseline COPD inpatient costs, baseline COPD office visit countsPage 9 of 21
costs, baseline all-cause inpatient costs, baseline all-cause EDcosts, baseline all-cause office visit costs, baseline all-cause otheroutpatient visit costs, baseline COPD office visit countsOtherOutpatientcostsCOPDPharmacycostsTime to firstCOPDexacerbationFemale, health plan type, Medicare advantage, index treatingprovider specialty, baseline diabetes mellitus, baseline dyspnea,baseline congestive heart failure, baseline hypertension, baselinerenal disease, baseline obstructive sleep apnea, baselinepneumonia, age, baseline Elixhauser comorbidity index score,baseline COPD total costs, baseline COPD total medical costs,baseline exacerbation episode costs, baseline all-cause inpatientuse, baseline all-cause ED use, baseline COPD inpatient use,baseline COPD office visit use, baseline COPD other outpatientuse, baseline all-cause ED counts, baseline COPD office visitcounts, baseline COPD outpatient counts, baseline all-causemedical costs, baseline all-cause inpatient costs, baseline all-causeED costs, baseline all-cause office visit costs, baseline all-causeother outpatient visit costs, baseline COPD inpatient costs, baselineCOPD office visit countsRegion of residence, index treating provider specialty, index year(2014-17), baseline diabetes mellitus, baseline dyspnea, baselineischemic heart disease, baseline pneumonia, age, baseline COPDtotal costs, baseline COPD total medical costs, baselineexacerbation counts, baseline exacerbation episode costs, baselineall-cause ED use, baseline all-cause office visit use, baseline allcause ED counts, baseline all-cause office visit counts, baselineCOPD office visit counts, baseline COPD outpatient counts,baseline all-cause total costs, baseline all-cause medical costs,baseline all-cause inpatient costs, baseline all-cause otheroutpatient visit costsGOLD AGOLD BFemale, region of residence,Female, region of residence,health plan type, MedicareMedicare advantage, index yearadvantage, index treating(2014-17), baseline diabetesprovider specialty, index yearmellitus, baseline dyspnea,(2014-17), baseline anxiety,baseline hypertension, baselinebaseline chronic sinusitis,ischemic heart disease, baselinebaseline myocardial infarction, renal disease, baselinebaseline osteoporosis, baselinepneumonia, age, baseline COPDMedicare advantage, baseline diabetes mellitus, baseline dyspnea,baseline congestive heart failure, baseline pneumonia, baselineElixhauser comorbidity index score, baseline COPD total costs,baseline COPD total medical costs, baseline all-cause ED flag,baseline all-cause office visit flag, baseline COPD inpatient flag,baseline COPD other outpatient flag, baseline all-cause inpatientcounts, baseline all-cause ED counts, baseline COPD ED visit counts,baseline COPD outpatient counts, baseline all-cause medical costs,baseline all-cause ED costs, baseline all-cause other outpatient visitcosts, baseline COPD ED costs, baseline COPD outpatient countsIndex treating provider specialty, index year (2014-17), baselineanxiety, baseline diabetes mellitus, baseline dyspnea, baselinecongestive heart failure, baseline renal disease, baseline COPD totalcosts, baseline COPD total medical costs, baseline all-cause ED flag,baseline all-cause other outpatient visit flag, baseline all-cause officevisit counts, baseline COPD outpatient counts, baseline all-cause totalcosts, baseline all-cause medical costs, baseline all-cause inpatientcosts, baseline all-cause office visit costs, baseline all-cause otheroutpatient visit costs, baseline COPD outpatient countsGOLD CFemale, index treating providerspecialty, baseline congestiveheart failure, baselineexacerbation counts, baselinesevere exacerbation counts,baseline moderate exacerbationepisode costsPage 10 of 21GOLD DMedicare advantage, baselinechronic sinusitis, baselinehypertension, age, baselineElixhauser comorbidity indexscore, baseline COPD total costs,baseline COPD total medicalcosts, baseline exacerbation
Number ofCOPDinpatientadmissionsNumber ofCOPD EDvisitspneumonia, age, baselineElixhauser comorbidity indexscore, baseline exacerbationcountsRegion of residence, Medicareadvantage, index treatingprovider specialty, index year(2014-17), baseline dyspnea,baseline congestive heartfailure, baseline peripheralvascular disease, baseline renaldisease, age, baselineElixhauser comorbidity indexscore, baseline all-causeinpatient use, baseline all-causeED use, baseline all-causeother outpatient visit use,baseline COPD office visit use,baseline COPD inpatientcounts, baseline COPD EDvisit counts, baseline COPDoffice visit counts, baselineCOPD outpatient counts,baseline all-cause office visitcostsFemale, index treating providerspecialty, index year (2014-17),baseline anxiety, baselinemyocardial infarction, age,baseline Elixhausercomorbidity index score,baseline exacerbation episodecosts, baseline all-cause EDuse, baseline all-cause officevisit use, baseline COPDinpatient use, baseline COPDtotal costs, baseline COPD totalmedical costs, baselineexacerbation countsRegion of residence, Medicareadvantage, index treatingprovider specialty, baselinecongestive heart failure, baselinemyocardial infarction, baselineangina pectoris, baselineischemic heart disease, baselinepneumonia, age, baselineElixhauser comorbidity indexscore, baseline exacerbationcounts, baseline all-cause EDflag, baseline COPD inpatientflag, baseline COPD office visitflag, baseline all-cause inpatientcounts, baseline all-causeoutpatient counts, baselineCOPD inpatient counts, baselineCOPD ED visit counts, baselineCOPD office visit counts,baseline COPD outpatientcounts, baseline all-cause totalcosts, baseline all-cause medicalcosts, baseline all-cause EDcosts, baseline COPD ED costsRegion of residence, Medicareadvantage, index treatingprovider specialty, index year(2014-17), baseline anxiety,baseline ischemic heart disease,age, baseline exacerbationcounts, pre-index all-causeinpatient flag, baseline all-causeED flag, baseline COPDinpatient flag, baseline COPDED flag, baseline COPD othercounts, baseline moderateexacerbation episode costsFemale, baseline ischemic heartdisease, age, baseline Elixhausercomorbidity index score, baselineCOPD total medical costs,baseline exacerbation counts,baseline COPD inpatient flag,baseline all-cause inpatientcounts, baseline COPD inpatientcostsMedicare advantage, indextreating provider specialty,baseline dyspnea, baselinecongestive heart failure, baselinepneumonia, age, baselineElixhauser comorbidity indexscore, baseline COPD total costs,baseline COPD total medicalcosts, baseline exacerbationcounts, baseline COPD inpatientflag, baseline all-cause EDcounts, baseline all-cause officevisit counts, baseline COPDinpatient counts, baseline COPDoutpatient counts, baseline allcause inpatient costs, baseline allcause ED costs, baseline COPDoutpatient countsBaseline chronic sinusitis,baseline obstructive sleep apnea,baseline all-cause ED flag,baseline COPD inpatient flag,baseline COPD ED flag, baselineall-cause ED counts, baselineCOPD inpatient countsRegion of residence, Medicareadvantage, baseline anxiety,baseline dyspnea, baselineischemic heart disease, baselineosteoporosis, baselineexacerbation episode costs,baseline COPD ED flag, baselineall-cause inpatient counts,baseline all-cause ED counts,baseline COPD ED visit counts,baseline all-cause inpatient costsPage 11 of 21
ED use, baseline all-causeinpatient counts, baseline allcause ED counts, baselineCOPD ED visit counts,baseline COPD outpatientcountsNumber ofCOPD officevisitsFemale, index treating providerspecialty, index year (2014-17),baseline anxiety, baselinediabetes mellitus, baselinedyspnea, baseline congestiveheart failure, baseline acuteischemic heart disease, baselineperipheral vascular disease,baseline pneumonia, age,baseline COPD total costs,baseline COPD total medicalcosts, baseline exacerbationcounts, baseline exacerbationepisode costs, baseline allcause office visit use, baselineall-cause other outpatient visituse, baseline COPD office visituse, baseline COPD otheroutpatient use, baseline allcause inpatient counts, baselineall-cause office visit counts,baseline all-cause outpatientcounts, baseline COPDinpatient counts, baselineCOPD office visit counts,baseline all-cause total costs,baseline all-cause medicalcosts, baseline all-causeinpatient costs, baseline allcause ED
provider specialty, index year (2014-17), baseline anxiety, baseline dyspnea, baseline congestive heart failure, baseline angina pectoris, baseline renal disease, baseline obstructive sleep apnea, baseline pneumonia, age, baseline Elixhauser comorbidity index score, baseline COPD total medical costs, baseline exacerbation episode
Page 1 of 9 Rapid Regulatory Courses in HealthStream Getting Started Tip Sheet Please note: Everyone is required to take two compliance trainings titled: Rapid Regulatory Compliance: Non-clinical I Rapid Regulatory Compliance: Non-clinical II Depending on your position at CHA, you may have more courses on your list. One must complete them all.File Size: 1MBPage Count: 9Explore furtherRapid Regulatory Compliance: Clinical II - KnowledgeQ .quizlet.comRapid Regulatory Compliance: Clinical I - An HCCS .quizlet.comRapid Regulatory Compliance: Non-clinical II-KnowledgeQ .quizlet.comThe Provider Compliance Tip fact sheets are now available .www.cms.govRapid Regulatory Compliance - Non-Clinical - Part Istudyres.comRecommended to you b
an extensive bibliography. The Report and its Supplementary Materials were jointly approved by the Commission on Arbitration and ADR at its meeting in Washington on 17 September 2016. Some sections of the Supplementary Materials have been updated prior to publication. Task Force Co -Chairs Georges Affaki . Claudia Salomon . Workstream leaders
Health Care Compliance Association (HCCA) Audit & Compliance Committee Conference Communicating with The Audit & Compliance Committee of the Board . Compliance Contract Compliance Board Structure & Leadership Competition Alliances Debt Management Planning/ Budgeting Payer Contracting Diagnostic and Treatment
Compliance Supplement must review the Legal Services Corporation Act, 42, U.S.C. § 2996 et seq., (LSC Act) and regulations (including the regulations' supplementary information) to obtain an understanding of the compliance requirements. The compliance requirements summarized in this Compliance Supplement reflect those
Local Assistance Procedures Manual Exhibit 16-T1 Materials Requiring a Certificate of Compliance per Caltrans Standard Specifications Exhibit 16-T1 Materials Requiring a Certificate of Compliance per Caltrans Standard Specifications Table 6-2.3 Materials Accepted by Certificate of Compliance (1 of 7)
3 THE COMPLIANCE GUIDE – INTRODUCTION THE COMPLIANCE GUIDE – INTRODUCTION 4 Defining Ethics and Compliance Compliance means adherence to, or conformance with laws or regulations and with an organisation’s standards, policies, and procedures. From a legal perspective, compliance is the way organisations seek to ensure that they, their
Welcome to the 2016 Compliance Trends Survey report, a joint effort between Deloitte and Compliance Week, which gauges the scope and complexity of the modern compliance function. In this, we have brought together Deloitte’s deep insight and experience and Compliance Week’s broad industry experience to gauge how well compliance and ethics
NIMS Compliance Checklist Deadline for Compliance is September 30, 2006 Standard Compliance Requirements Compliance Applies To: Notes Documentation Required Compliance Date 1. Adoption of NIMS All Governments, non-government organizations, and private sector incident management/response org
